Abeona therapeutics issues letter to stockholders

New york and cleveland, may 26, 2021 (globe newswire) -- abeona therapeutics inc. (nasdaq: abeo), a fully-integrated leader in gene and cell therapy, today issued the following letter to stockholders in conjunction with the 2021 abeona therapeutics annual meeting of stockholders to be held today, may 26, 2021:
ABEO Ratings Summary
ABEO Quant Ranking